The key principle is selective absorption: the Grotthuss–Draper law states that optical radiation can produce a photobiological effect only when it is absorbed by the relevant tissue or chromophore. For an aesthetic treatment device, effective biological dose is therefore determined not by total emitted energy alone, but by the device’s spectral irradiance, exposure time, and the target reaction’s wavelength sensitivity.

Energy should be selected at wavelengths that the intended chromophore or tissue can absorb, then converted into a biologically weighted dose using the relevant spectral action curve. This prevents the common mistake of treating every joule delivered to the skin as equally effective—or equally safe.

What the Grotthuss–Draper Law Actually Governs

Absorption is a prerequisite for effect

The law establishes a necessary condition for photobiological action: light must be absorbed by a biological target before it can initiate a reaction.

In optical aesthetic devices, that target may be a chromophore or tissue structure associated with the desired outcome. Light that is reflected, transmitted, or absorbed elsewhere contributes little or nothing to the intended reaction, although it may still create unwanted effects.

Absorption does not determine the entire response

Absorption alone does not guarantee a particular magnitude of biological response. Two wavelengths may both be absorbed, yet produce different outcomes because the underlying biological reaction has different wavelength sensitivity.

This is why energy selection must consider both where light is absorbed and how strongly the target reaction responds at each wavelength.

How It Guides Energy Selection

Choose wavelengths that reach the intended target

The first selection criterion is the spectral relationship between the device output and the intended tissue or chromophore. A wavelength is useful only when sufficient radiation reaches and is absorbed by the relevant target.

A device emitting substantial energy outside the target’s effective absorption region may deliver a high physical dose without delivering a correspondingly high biological dose.

Match the spectrum to the desired reaction

The target reaction has its own spectral action curve, represented as (s_{\text{actinic}}(\lambda)). This curve describes the relative effectiveness of different wavelengths in initiating that specific photobiological response.

Consequently, the optimal spectrum is not necessarily the one with the highest total output. It is the one that delivers energy where the desired reaction is both accessible through absorption and biologically responsive.

Account for unwanted absorption

Skin contains multiple absorbing structures, and not all absorbed energy contributes to the intended treatment effect. Radiation absorbed by surrounding tissue can increase risks such as erythema or other unintended reactions.

Energy selection should therefore maximize the intended target response while limiting spectral regions that disproportionately stimulate unwanted biological effects.

How to Calculate the Biologically Effective Dose

Start with spectral irradiance

The device’s spectral irradiance, (E_{e,\lambda}), describes the radiant power delivered per unit area across wavelength.

Unlike a single total irradiance value, spectral irradiance preserves the information needed to determine which portions of the output are relevant to the biological target.

Apply the action spectrum

The actinic or biologically effective dose can be represented as:

[ H_{\text{actinic}}

\int_{0}^{t} \int_{\lambda} E_{e,\lambda}(\lambda,\tau), s_{\text{actinic}}(\lambda) ,d\lambda,d\tau ]

If the spectral irradiance is constant during exposure, this simplifies to:

[ H_{\text{actinic}}

t\int_{\lambda} E_{e,\lambda}(\lambda), s_{\text{actinic}}(\lambda) ,d\lambda ]

Here:

(H_{\text{actinic}}) is the action-weighted biological dose.
(E_{e,\lambda}) is spectral irradiance.
(s_{\text{actinic}}(\lambda)) is the spectral action curve for the reaction.
(t) is exposure time.
The wavelength integral sums the contribution across the device spectrum.

The action curve is typically normalized, so the resulting value is a relative or weighted effective dose unless the curve and measurement system are explicitly calibrated to absolute biological units.

Why total fluence is insufficient

Physical fluence is commonly expressed as energy per unit area:

[ H = E_e t ]

That quantity is useful, but it does not indicate how much of the energy is relevant to the selected biological reaction. Two devices can deliver the same fluence while producing different biological effects because their spectra differ.

The action-weighted calculation resolves this by assigning greater importance to wavelengths that are more effective for the target reaction.

Incorporate absorption into practical interpretation

The action-weighted formula describes spectral effectiveness, but treatment planning must also consider whether the selected radiation is actually absorbed by the target at the treatment depth.

In practical terms, the effective response depends on the combination of:

Spectral delivery from the device.
Propagation and absorption within the skin.
Biological action at each wavelength.
Exposure duration and spatial dose.

The Grotthuss–Draper law supplies the essential physical filter: radiation that does not reach and become absorbed by the relevant target cannot directly initiate the intended photobiological process.

Why This Matters for Device Dosimetry

Radiometric dose and biological dose are different

Radiometric quantities describe what the device emits or delivers, such as irradiance, radiant exposure, and spectral irradiance.

Biological dose describes the portion of that radiation that is relevant to a particular reaction. It is therefore reaction-specific: the same device exposure can have different effective doses for different biological endpoints.

Calibration must reflect the delivered spectrum

A reliable calculation requires knowledge of the actual spectrum at the treatment plane, not merely the nominal wavelength printed in a device specification.

The measurement should account for the device’s spectral output, exposure time, treatment area, and operating conditions. A nominal wavelength or rated power alone cannot establish the biological dose.

Spatial distribution also matters

The calculation should be applied to the radiation delivered across the treated area. Nonuniform output can create regions of under-treatment and over-treatment even when the average fluence appears correct.

For pulsed systems, the relevant exposure must include the actual temporal output rather than assuming that nominal pulse settings perfectly describe delivered energy.

Understanding the Trade-offs

Higher energy is not automatically better

Increasing energy can increase the action-weighted dose, but it can also increase absorption by non-target tissue and the likelihood of unwanted reactions such as erythema.

The objective is not maximum emitted energy. It is sufficient target-specific dose with an acceptable safety margin.

A strongly absorbed wavelength may have limited penetration

A wavelength can be highly absorbed near the skin surface yet contribute less to a deeper target if it does not penetrate adequately.

Energy selection must therefore balance target absorption, treatment depth, action-spectrum effectiveness, and off-target absorption.

Action curves are endpoint-specific

An action curve for one photobiological reaction should not automatically be used to calculate the dose for another. The relevant curve must correspond to the biological endpoint being evaluated.

Using an inappropriate action spectrum can produce a mathematically precise but biologically misleading dose estimate.

Individual skin responses vary

The same delivered dose may not create the same clinical response across all individuals or treatment sites. Skin optical properties, target concentration, tissue depth, and baseline sensitivity can affect how much radiation is absorbed and how the tissue responds.

For that reason, action-weighted dose is an essential dosimetry tool, but it does not eliminate the need for device validation, clinical protocols, and appropriate safety controls.

How to Apply This to Your Project

Use the following framework when selecting energy and calculating dose:

If your primary focus is target efficacy: Select a spectrum that reaches the intended target and overlaps strongly with both its absorption characteristics and the relevant spectral action curve.
If your primary focus is safety and erythema reduction: Calculate the action-weighted dose rather than relying only on total fluence, and limit wavelengths likely to create substantial non-target absorption.
If your primary focus is device calibration: Measure spectral irradiance at the treatment plane, integrate it across wavelength and exposure time, and document the treatment area and temporal output.
If your primary focus is biological interpretation: Treat (H_{\text{actinic}}) as reaction-specific and verify that the selected action curve corresponds to the endpoint being assessed.

The Grotthuss–Draper law turns wavelength selection from a power-setting exercise into a target-absorption and biological-effectiveness problem, enabling more rational and safer optical treatment dosimetry.

Summary Table:

Aspect	Description
Core Principle	Absorption is prerequisite for photobiological effect
Energy Selection	Wavelengths must be absorbed by target chromophore & match action spectrum
Dose Calculation	Action-weighted dose integrates spectral irradiance with action spectrum
Clinical Implication	Radiometric dose ≠ biological dose; safety depends on target-specific absorption

Ready to optimize your optical aesthetic devices with precise dosimetry? Our experts at BELIS specialize in advanced laser and light systems. Contact us today to discuss how our solutions maximize efficacy while ensuring safety.